11/15
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
New research from Penn Medicine shows suppressing these neurons may be a promising target for therapies to treat stress-related sleep disorders, like insomnia and PTSD.
The therapy tested in a Phase 1 clinical trial might drastically change the way the T cells work, potentially allowing the new CAR T cell product to work where other products have failed.
A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.
Collaborative research communities supported by the Environmental Innovations Initiative are addressing issues related to climate action, stewardship of nature, and societal resilience.
Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.
A preclinical Penn Medicine study explains the previously observed anti-cancer effect of the common anesthetic drug.
Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.
An immersive program at the Perelman School of Medicine gives high school students a sneak peek at a potential future in the medical field.
The tension-activated repair patch plugs holes in discs in the spine like car tire patches, and could prevent further disease progression.
A Penn Medicine study shows that patient pain scores are a good predictor for opioid use, but younger patients and those who hadn’t used opioids before are less likely to take them.
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Bruce Brod of the Perelman School of Medicine says that there’s no evidence to show beef tallow is better than conventional moisturizers.
FULL STORY →
The STEM Goes Red event hosted at Penn Medicine showed young Philadelphia women in high school how to program miniature computers, with remarks from Helene Glassberg of the Perelman School of Medicine.
FULL STORY →
Daniel Baker, a Ph.D. student in Carl June’s lab at the Perelman School of Medicine, discusses the results of a study on donor CAR-T cell therapy.
FULL STORY →
Jason Karlawish of the Perelman School of Medicine says that some reactions to new Alzheimer’s drugs can resemble flu-like symptoms, such as chills, shortness of breath, and rash.
FULL STORY →
In an opinion essay, postdoc Emily Pfender of the Leonard Davis Institute and Perelman School of Medicine cautions that social media can set back women’s health by perpetuating fear and misinformation instead of empowering informed choices.
FULL STORY →
Garret FitzGerald of the Perelman School of Medicine says that the timing of medication dosing can substantially influence the drug levels in people’s blood.
FULL STORY →